Gavreto 100 mg, Hartkapseln

7680681820017 CH-68182 Kapseln

Associated product:

Gavreto 100 mg, Hartkapseln
Gavreto 100 mg, Hartkapseln
Gavreto 100 mg, Hartkapseln
1 / 2
google

Article details

Package size
120
Selling units
120
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
20/12/2024
Patient information leaflet
Français
20/12/2024
Patient information leaflet
Italien
20/12/2024
Summary of Product Characteristics
Allemand
20/12/2024
Summary of Product Characteristics
Français
20/12/2024
Summary of Product Characteristics
Italien
20/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
22.3 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK

Authorization holder

Blueprint Medicines (Switzerland)

6300 Zug

Authorization information

Swissmedic authorization number
68182
Drug name
Gavreto, Hartkapseln
Galenic form
KAHA
ATC Code
L01EX
Authorization status
BA
Dispensing category
A
First authorization
12/08/2021
Authorization expiration date
27/09/2025
IT Number
07.16.1.
Domain
Human medicine
Field of application
Nichtkleinzelliges Lungenkarzinom mit Rearrangement des RET (Rearranged during Transfection)-Gens; RET-Fusion-positives Schilddrüsenkarzinom

Package details

Description (FR)
GAVRETO caps 100 mg bte 120 pce
Description (DE)
GAVRETO Kaps 100 mg Ds 120 Stk
Market withdrawal
12/08/2023
Narcotic (BTM)
No